Opens profile photo
Follow
LabScribbles
@LabScribbles
Open access Huntington's disease research by Dr Rachel Harding, she/her, SGC Toronto, zenodo.org/communities/la
Toronto, Ontariolabscribbles.comJoined December 2015

LabScribbles’s Tweets

Just Published/The Scientist. In this opinion piece I share my thoughts on the new publishing model and what is needed to change the publishing system All of us must commit to taking the risks needed to change how research is shared and evaluated
4
76
Show this thread
Congratulations on this well deserved award!
Quote Tweet
We are excited to announce the recipient of the 2022 NAVIGATOR Research Program, Prof. Cheryl Arrowsmith from the University of Toronto. For more information on the NAVIGATOR Research Program and past recipients, visit huntingtonsociety.ca/navigator-prog
Image
8
Please RT. This is a wonderful opportunity to work with the amazing Rachel Harding who leads our #Huntingtonsdisease program. Join us to help tackle this terrible disease.
Quote Tweet
The SGC Laboratory at U of T is seeking a Postdoctoral fellow to join our Huntington’s disease research team. Do you have Ph.D. degree in biochemistry, biophysics, structural biology or related field? For more details visit bit.ly/3u25774 #Structuralbiology #hiringnow
2
12
Come share a lab bench with me in Toronto! Fun group doing exciting research on Huntington's disease, with a focus on structural biology/biochemistry and proteomics. Please like/share/RT/ping/poke/whatever the kids do these days #postdocjobs #chemtwitter #AcademicTwitter
Quote Tweet
The SGC Laboratory at U of T is seeking a Postdoctoral fellow to join our Huntington’s disease research team. Do you have Ph.D. degree in biochemistry, biophysics, structural biology or related field? For more details visit bit.ly/3u25774 #Structuralbiology #hiringnow
Image
7
Branaplam was originally designed to treat spinal muscular atrophy, but a new paper outlines how it could hold promise for treating Huntington’s. This oral drug lowers huntingtin protein and will now be tested in a study called VIBRANT-HD.
2
58
A new imaging tool means that scientists can now directly measure the levels of the toxic huntingtin protein in animal models of Huntington’s disease, letting us see how well huntingtin lowering therapies are working in their brains
1
34
Looks to be potentially exciting news from Roche and Ionis on the status of tominersen! We'll watch the community update on Thursday, and expect a Buzz story with details to follow.
Quote Tweet
Very exciting update from @Roche and @ionispharma about their Huntingtin-lowering drug, tominersen. A new phase II study in earlier stage HD is apparently being planned... ir.ionispharma.com/news-releases/
Show this thread
4
63
Thanks to all of my wonderful coauthors and collaborators (those on twitter are tagged above) for their hard work and support. This was a real team effort and I am extremely grateful for all of your expertise and insight throughout this project.
1
3
Show this thread
New tools let us “see” clumps of toxic huntingtin protein which build up in the brains of people with Huntington’s disease over time. Tracking these clumps might help us to better understand how HD progresses or how treatments might slow or halt HD.
1
42